Document is current
Any future updates will be listed below
-
Authors
Hidaka, Naoko
Kimura, Soichiro
Watanabe, So
Akiyama, Tomoyuki
Tachikawa, Kanako
Michigami, Toshimi
Adachi, Natsuho
Irie, Koki
Hoshino, Yoshitomo
Kato, Hajime
Nangaku, Masaomi
Tanaka, Sakae
Makita, Noriko
Saito, Taku
Ito, Nobuaki https://orcid.org/0000-0002-4071-5372
-
Funding
Funding for this research was provided by:
The University of Tokyo
- License Information
-
More Information
Article History
Received: 13 April 2026
Accepted: 8 July 2026
First Online: 15 July 2026
Declarations
Conflict of interest: M. Nangaku receives research support and honoraria from Kyowa Kirin Co., Ltd. Nobuaki Ito receives research funding from Alexion AstraZeneca Rare Disease. The Division of Therapeutic Development for Intractable Bone Diseases, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, is an endowed department supported by Kyowa Kirin Co., Ltd. All other authors have nothing to disclose.
